Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Hyperplasia × semaglutide × Other × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other 1 Gynecologic 1

Conditions

Obesity 5 Polycystic Ovary Syndrome 3 Overweight 1 Neoplasms 1 Metabolic Syndrome 1 Inflammation 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Dyslipidemias 1

Interventions

Progestins 2 semaglutide 1 Tirzepatide 1 Resistance Training 1 Nutrition Assessment 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Hysteroscopy 1 Estrogen Replacement Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07462663 2026-03-10

SHAPE-ENDO

Hospital Universitari de Bellvitge

Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡